Litcius/Paper detail

A systemic analysis of monocarboxylate transporters in ovarian cancer and possible therapeutic interventions

Priti Chatterjee, D. Bhowmik, Sib Sankar Roy

2023Channels24 citationsDOIOpen Access PDF

Abstract

experiments in EOC cell lines, SKOV3 and OAW-42. MCT1 and MCT4 were found to be upregulated at the mRNA level in OC tissues compared to normal. However, only higher level of MCT4 mRNA was found to be associated with poor patient survival. MCT4 was positively correlated with gene families responsible for invasion, migration, and immune modification, proving it to be one of the most important MCTs for therapeutic intervention. We compared the effects of MCT1/2 blocker SR13800 and a broad-spectrum MCT blocker α-Cyano Hydroxy Cinnamic Acid (α-CHCA) and discovered that α-CHCA has a greater effect on diminishing the invasive behavior of the cancer cells than MCT1/2 blocker SR13800. From our study, MCT4 has emerged as a prospective marker for predicting poor patient outcomes and a potential therapeutic target.

Topics & Concepts

Ovarian cancerMonocarboxylate transporterBasiginTransporterCancer researchIn silicoCarcinogenesisDownregulation and upregulationCancerBiologyChemistryInternal medicineCell biologyGeneMedicineBiochemistryMatrix metalloproteinaseCancer, Hypoxia, and MetabolismEpigenetics and DNA MethylationRNA modifications and cancer